4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy has been researched along with Koch's Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, HD; Britton, WJ; Chami, B; Hortle, E; Kaur, A; New, EJ; Oehlers, SH; Robertson, SI; Witting, PK; Xu, W | 1 |
1 other study(ies) available for 4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy and Koch's Disease
| Article | Year |
|---|---|
The cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targets.
Topics: Animals; Antioxidants; Bacterial Proteins; Cyclic N-Oxides; Disease Models, Animal; Humans; Macrophages; Mycobacterium marinum; Mycobacterium tuberculosis; Reactive Oxygen Species; Tuberculosis; Zebrafish | 2019 |